Understanding the Diagnosis of Pituitary Gigantism
At a Glance
Pituitary gigantism usually results from a benign pituitary tumor that makes too much growth hormone before growth plates close. Diagnosis and care focus on hormone levels, vision, genetic causes, and treatment by an experienced pediatric pituitary team.
Finding out you or your child has pituitary gigantism can be an overwhelming experience. You may feel a mix of shock, confusion, or even a sense of relief to finally have an explanation for the rapid growth. While this condition is serious and requires expert care, it is important to know that the cause is almost always a benign (non-cancerous) tumor [1]. It is not brain cancer, and it does not spread to other parts of the body [1].
Because this condition is exceptionally rare, many local doctors may have never treated a case [2]. For this reason, your care should be managed by a specialized multidisciplinary team, usually at a major children’s hospital, including a pediatric endocrinologist and a neurosurgeon with specific experience in pituitary tumors [3].
Understanding the Growth Signal
The growth we see in children and teens is usually a carefully balanced process. In pituitary gigantism, a small growth—usually an adenoma (a benign tumor), though sometimes an overgrowth of cells—forms on the pituitary gland, a pea-sized “master gland” at the base of the brain [4].
This tissue begins overproducing Growth Hormone (GH). This excess GH travels to the liver, signaling it to produce high levels of another hormone called Insulin-like Growth Factor-1 (IGF-1) [4][5]. Together, these hormones act like a constant “green light” for the body to grow. They specifically target the epiphyses (growth plates), which are the areas of developing cartilage at the ends of long bones [4]. Because children’s growth plates are still “open” and haven’t fused yet, the excess hormones cause the bones to lengthen rapidly, leading to extreme height [4][6].
Gigantism vs. Acromegaly
You may hear the term acromegaly used in discussions about growth hormone. The difference between the two is simply a matter of timing:
- Pituitary Gigantism occurs in children and adolescents whose growth plates are still open. The primary result is a dramatic increase in height [2].
- Acromegaly occurs in adults after the growth plates have closed. Since the bones can no longer get longer, they instead become thicker. This leads to changes in facial features, such as a prominent brow or jaw, and enlargement of the hands and feet [7].
If the condition is not treated before their growth plates close, they may eventually develop these acromegalic features in addition to their height [8].
Symptoms Beyond Height
While rapid growth is the most visible sign, the tumor and the hormones it produces can cause other symptoms that you should watch for:
- Vision Changes: Large tumors can press against the optic chiasm (the part of the brain where the optic nerves cross). This can cause blurred vision or a loss of peripheral vision, sometimes without the person even realizing it [9][10].
- Headaches: Frequent or severe headaches can occur due to stretching of tissues, hormone changes, or local effects from the tumor [11].
- Physical Changes: You might notice shoe or hat size increasing very quickly, or they may sweat more than usual (hyperhidrosis) [12].
- Hormonal Shifts: The tumor can sometimes interfere with other hormones, leading to late puberty or irregular menstrual cycles in older children [13].
Why Genetic Testing Matters
In up to half of all cases of pediatric pituitary gigantism seen at specialized centers, there is an underlying genetic cause [6]. Identifying a specific genetic marker can help doctors understand the condition and whether other family members should be screened.
- AIP Mutation: This is the most common genetic link in some cohorts and is often associated with larger tumors that appear at a younger age [9].
- X-LAG (X-linked acrogigantism): This rare form usually begins in very early infancy (before age 5) and is caused by a specific duplication on the X chromosome [14][15].
- Other Syndromes: Conditions like McCune-Albright Syndrome or Carney Complex can also be involved [6].
The Importance of Specialized Care
Because pituitary gigantism is so rare, “standard” pediatric care is often not enough. Expert consensus recommends that patients be treated at centers with multidisciplinary pituitary teams [3]. These teams have the experience to perform delicate surgeries—often through the nose (transsphenoidal surgery) to avoid opening the skull—and to manage the complex hormonal balance required for healthy development [16][17].
While the road ahead involves many tests and specialists, the goal of treatment is to stop the abnormal growth, protect vision, and ensure hormone levels return to a safe range [3]. It is helpful to know that while treatment aims to prevent complications, it generally cannot reverse the height or bone lengthening that has already occurred.
Common questions in this guide
What usually causes pituitary gigantism?
What does an IGF-1 level tell doctors?
What symptoms can occur besides unusually rapid growth?
Why might a child with pituitary gigantism need genetic testing?
Which specialists should manage pituitary gigantism?
How is pituitary gigantism treated?
Can treatment reverse height that has already developed?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many pediatric pituitary surgeries has your neurosurgeon performed in the last year?
- 2.What is the current IGF-1 level compared to the normal range for their age and pubertal stage?
- 3.Has the tumor reached or compressed the optic chiasm, and what does that mean for vision?
- 4.Which specific genetic tests (such as AIP or GPR101) do you recommend, and how will those results change the treatment plan?
- 5.What is the plan for monitoring other hormones, like those for the thyroid and adrenal glands, after surgery?
- 6.If surgery doesn't fully control the growth hormone levels, what are our options for medication or other therapies?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Novel Genetic Causes of Pituitary Adenomas.
Caimari F, Korbonits M
Clinical cancer research : an official journal of the American Association for Cancer Research 2016; (22(20)):5030-5042 doi:10.1158/1078-0432.CCR-16-0452.
PMID: 27742789 - 2
Genetics of gigantism and acromegaly.
Hannah-Shmouni F, Trivellin G, Stratakis CA
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2016; (30-31()):37-41 doi:10.1016/j.ghir.2016.08.002.
PMID: 27657986 - 3
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases.
Korbonits M, Blair JC, Boguslawska A, et al.
Nature reviews. Endocrinology 2024; (20(5)):290-309 doi:10.1038/s41574-023-00949-7.
PMID: 38336898 - 4
Growth hormone signaling and clinical implications: from molecular to therapeutic perspectives.
Aghili ZS, Khoshnevisan G, Mostoli R, et al.
Molecular biology reports 2025; (52(1)):202 doi:10.1007/s11033-025-10304-w.
PMID: 39904816 - 5
Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver.
Zhang Y, Wang M, Ji C, et al.
iScience 2021; (24(9)):102983 doi:10.1016/j.isci.2021.102983.
PMID: 34485865 - 6
Genetics of Acromegaly and Gigantism.
Bogusławska A, Korbonits M
Journal of clinical medicine 2021; (10(7)) doi:10.3390/jcm10071377.
PMID: 33805450 - 7
An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism.
Asa SL, Ezzat S
Journal of clinical medicine 2021; (10(11)) doi:10.3390/jcm10112254.
PMID: 34067494 - 8
Skin lesions in patients treated with growth hormone and those with growth hormone excess: a current overview.
Matwiejuk M, Myśliwiec H, Miklosz A, et al.
Frontiers in medicine 2026; (13()):1777658 doi:10.3389/fmed.2026.1777658.
PMID: 41907289 - 9
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Rostomyan L, Daly AF, Petrossians P, et al.
Endocrine-related cancer 2015; (22(5)):745-57 doi:10.1530/ERC-15-0320.
PMID: 26187128 - 10
Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
Kim TG, Jin KH, Kang J
International ophthalmology 2019; (39(1)):21-31 doi:10.1007/s10792-017-0778-x.
PMID: 29274021 - 11
Mammosomatotroph pituitary neuroendocrine tumour in a 7-year-old boy: case report.
Lin W, Qiu Y, Ma Z, et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2026; (42(1)).
PMID: 41843183 - 12
Pituitary gigantism: a case series from Hospital de San José (Bogotá, Colombia).
García WR, Cortes HT, Romero AF
Archives of endocrinology and metabolism 2019; (63(4)):385-393 doi:10.20945/2359-3997000000150.
PMID: 31365626 - 13
Two Unusual Cases of Pituitary Tumors Presenting with Pediatric Acromegaly.
Gurnurkar S, Patel U, Seekford J, et al.
Cureus 2022; (14(11)):e31604 doi:10.7759/cureus.31604.
PMID: 36540490 - 14
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Iacovazzo D, Caswell R, Bunce B, et al.
Acta neuropathologica communications 2016; (4(1)):56 doi:10.1186/s40478-016-0328-1.
PMID: 27245663 - 15
X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
Beckers A, Lodish MB, Trivellin G, et al.
Endocrine-related cancer 2015; (22(3)):353-67 doi:10.1530/ERC-15-0038.
PMID: 25712922 - 16
Outcomes of Endoscopic Transsphenoidal Approach for More Aggressive Pediatric Pituitary Adenomas: Early- and Late-Term Results from a Single Center Experience.
Caklili M, Yilmaz E, Duman Ozturk S, et al.
World neurosurgery 2023; (176()):e623-e633 doi:10.1016/j.wneu.2023.05.111.
PMID: 37271260 - 17
Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.
Perry A, Graffeo CS, Marcellino C, et al.
Journal of neurological surgery. Part B, Skull base 2018; (79(1)):91-114 doi:10.1055/s-0038-1625984.
PMID: 29404245
This page explains pituitary gigantism and its evaluation for informational purposes only and does not constitute medical advice. A pediatric endocrinologist and pituitary-experienced neurosurgeon should interpret your or your child's results and recommend care.
Get notified when new evidence is published on Pituitary gigantism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.